After a reported 2M revenue compared to th3 145k expected, IMMP has been on a decent uptrend after finishing a double bottom.
If momentum continues, I can see a 3.09 IMMP easy
Blue box: Entry price
Red box: Stop loss
Green box: Take profit
Immutep hits a previous resistance and confirms it as a support,
we see oversold MACD and RSI which appear congruent with our idea of support.
IMMU can make its way to previous resistance now.
Trade Safe
Immutep is nearly ready to push back up to previous highs or higher. wait for a cross above and fall back to confirm support on the ema on the daily. wait for macd crossover.
Sell at previous highs / resistances.
IMMP has done great recovering from its last sell-off. But now it's back at a historic level of resistance that we clearly see on this chart right now. Upcoming potential catalyst this week will determine which direction it heads imo.
"Data from the TACTI-002 and INSIGHT-004 studies were published in abstracts on the 2021 ASCO Annual Meeting’s official...
Ok So I put lines everywhere from all over the place and in the confusion of it all some areas started to have some confluence.....everything kept pointing to $6.80. I appreciate the request to take a look at this.
by iCantw84it
05.27.2021
Please Like Subscribe if you would like to see more of these.
First time an antigen presenting cell (APC) activator has shown an Overall Survival (OS) benefit in a randomised setting in metastatic breast cancer patients known to be insensitive to immune checkpoint inhibitor therapy
Promising and improving overall trend in OS in total population (based on approx. 60% of events): median survival benefit of +2.7 months from...
The MACD is curling up and it tested the .50 Fibonacci level. Also a few days ago it tested the 200 MA and bounced. This looks like a breakout over 1.82 with a first target of 2.12
Immutep Ltd is a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune control mechanism. The company was originally built on CVac, a therapeutic cancer vaccine.
Break out of ascending Triangle confirms, Targeting Supply @ 0.30
- Ascending Triangle Confirms
- 4th touch on Fib .236 breaks
- Measured move lines up...
